103 related articles for article (PubMed ID: 38768411)
1. Expression of Concern: Human Anti-CXCR4 Antibodies Undergo VH Replacement, Exhibit Functional V-Region Sulfation, and Define CXCR4 Antigenic Heterogeneity.
Xu C; Sui J; Tao H; Zhu Q; Marasco WA
J Immunol; 2024 Jun; 212(11):1855. PubMed ID: 38768411
[No Abstract] [Full Text] [Related]
2. Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity.
Xu C; Sui J; Tao H; Zhu Q; Marasco WA
J Immunol; 2007 Aug; 179(4):2408-18. PubMed ID: 17675502
[TBL] [Abstract][Full Text] [Related]
3. VH and VL gene usage by anti-beta-amyloid autoantibodies in Alzheimer's disease: detection of highly mutated V regions in both heavy and light chains.
Fang Q; Kannapell CC; Fu SM; Xu S; Gaskin F
Clin Immunol Immunopathol; 1995 May; 75(2):159-67. PubMed ID: 7704974
[TBL] [Abstract][Full Text] [Related]
4. A rabbit antiserum detects a VH J558 subgroup marker highly expressed among anti-alprenolol antibodies.
Nahmias C; Cazaubon S; Strosberg AD
J Immunol; 1989 Feb; 142(3):871-6. PubMed ID: 2464029
[TBL] [Abstract][Full Text] [Related]
5. Antigenically distinct conformations of CXCR4.
Baribaud F; Edwards TG; Sharron M; Brelot A; Heveker N; Price K; Mortari F; Alizon M; Tsang M; Doms RW
J Virol; 2001 Oct; 75(19):8957-67. PubMed ID: 11533159
[TBL] [Abstract][Full Text] [Related]
6. Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases.
Seibert C; Veldkamp CT; Peterson FC; Chait BT; Volkman BF; Sakmar TP
Biochemistry; 2008 Oct; 47(43):11251-62. PubMed ID: 18834145
[TBL] [Abstract][Full Text] [Related]
7. Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.
Xu J; Deng X; Tang M; Li L; Xiao L; Yang L; Zhong J; Bode AM; Dong Z; Tao Y; Cao Y
PLoS One; 2013; 8(3):e56114. PubMed ID: 23472069
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of anti-idiotypic monoclonal antibodies in the HLA-DR antigenic system.
Armandola EA; Mariani SM; Zwickl M; Hardman N; Ferrone S
Eur J Immunol; 1992 Nov; 22(11):2893-9. PubMed ID: 1425914
[TBL] [Abstract][Full Text] [Related]
9. Gene repertoire of the anti-poly(Glu60Ala30Tyr10) (GAT) immune response: comparison of VH, V kappa, and D regions used by anti-GAT antibodies and monoclonal antibodies produced after anti-idiotypic immunization.
Roth C; Rocca-Serra J; Sommé G; Fougereau M; Théze J
Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4788-92. PubMed ID: 3927291
[TBL] [Abstract][Full Text] [Related]
10. VH and V kappa segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection.
Ikematsu H; Ichiyoshi Y; Schettino EW; Nakamura M; Casali P
J Immunol; 1994 Feb; 152(3):1430-41. PubMed ID: 8301143
[TBL] [Abstract][Full Text] [Related]
11. Sequence analyses of three immunoglobulin G anti-virus antibodies reveal their utilization of autoantibody-related immunoglobulin Vh genes, but not V lambda genes.
Huang DF; Olee T; Masuho Y; Matsumoto Y; Carson DA; Chen PP
J Clin Invest; 1992 Dec; 90(6):2197-208. PubMed ID: 1334971
[TBL] [Abstract][Full Text] [Related]
12. VH-gene representation in autoantibodies reflects the normal human B-cell repertoire.
Stewart AK; Huang C; Long AA; Stollar BD; Schwartz RS
Immunol Rev; 1992 Aug; 128():101-22. PubMed ID: 1427920
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of murine monoclonal anti-CD4. Epitope recognition, idiotype expression, and variable region gene sequence.
Lohman KL; Attanasio R; Buck D; Carrillo MA; Allan JS; Kennedy RC
J Immunol; 1992 Nov; 149(10):3247-53. PubMed ID: 1385519
[TBL] [Abstract][Full Text] [Related]
14. Restricted usage of VH and V kappa genes by murine monoclonal antibodies against 3-fucosyllactosamine.
Kimura H; Buescher ES; Ball ED; Marcus DM
Eur J Immunol; 1989 Sep; 19(9):1741-6. PubMed ID: 2571506
[TBL] [Abstract][Full Text] [Related]
15. Preferential use of a H chain V region in antitumor-associated glycoprotein-72 monoclonal antibodies.
Rixon MW; Gourlie BB; Kaplan DA; Schlom J; Mézes PS
J Immunol; 1993 Dec; 151(11):6559-68. PubMed ID: 8245485
[TBL] [Abstract][Full Text] [Related]
16. V genes of the primary antibody response of C57BL/10 mice to the hapten phenyloxazolone.
Kaartinen M; Pelkonen E; Even J; Mäkelä O
Eur J Immunol; 1988 Jul; 18(7):1095-100. PubMed ID: 3136024
[TBL] [Abstract][Full Text] [Related]
17. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of VH Replacement Products in IgH Genes Derived from Autoimmune Diseases and Anti-Viral Responses in Human.
Lange MD; Huang L; Yu Y; Li S; Liao H; Zemlin M; Su K; Zhang Z
Front Immunol; 2014; 5():345. PubMed ID: 25101087
[TBL] [Abstract][Full Text] [Related]
19. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin.
Kavaler J; Caton AJ; Staudt LM; Schwartz D; Gerhard W
J Immunol; 1990 Oct; 145(7):2312-21. PubMed ID: 2118933
[TBL] [Abstract][Full Text] [Related]
20. Sequences of the VH and VL regions of murine monoclonal antibodies against 3-fucosyllactosamine.
Kimura H; Cook R; Meek K; Umeda M; Ball E; Capra JD; Marcus DM
J Immunol; 1988 Feb; 140(4):1212-7. PubMed ID: 2893825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
